Advertisement

Splice Redirection as a Convenient Assay to Monitor CPP–ON Efficiency and Mechanism

  • Rachida Abes
  • Andrey A. Arzumanov
  • Amer F. Saleh
  • Fatouma Said Hassane
  • Michael J. Gait
  • Bernard Lebleu
Protocol
Part of the Methods in Molecular Biology book series (MIMB, volume 683)

Abstract

Several strategies based on synthetic oligonucleotides (ON) have been proposed to control gene expression. As for most biomolecules, however, delivery has remained a major roadblock for in vivo applications. Conjugation of steric-block neutral DNA mimics, such as peptide nucleic acids (PNA) or phosphorodiamidate morpholino oligonucleotides (PMO), to cell-penetrating peptides (CPP) has recently been proposed as a new delivery strategy. It is particularly suitable for sequence-specific interference with pre-mRNA splicing, thus offering various applications in fundamental research and in therapeutics. The chemical synthesis of these CPP–ON conjugates will be described as well as easy-to-implement assays to monitor cellular uptake, endosome leakage, and efficiency of splicing redirection.

Key words

Cell-penetrating peptides Oligonucleotides Splicing regulation Delivery Liposome leakage 

Notes

Acknowledgments

We thank R. Kole (University North Carolina) for providing the HeLa pLuc705 cell line. Amer Saleh was supported by the MRC-Technology Development Gap Fund and also by Action Duchenne. Rachida Abes was supported by Ligue Française contre le Cancer PhD fellowship and Fatouma Said Hassane by Association Française contre les Myopathies.

Studies funded by EC grant QLK3-CT-2002-01989 and CEFIPRA grant 3205.

References

  1. 1.
    Bauman, J., Jearawiriyapaisam N. and Kole, R. (2009) Therapeutic potential of splice-switching oligonucleotides. Oligonucleotides 19, 1–13.CrossRefPubMedGoogle Scholar
  2. 2.
    Wilton, S.D. and Fletcher, S. (2008) Exon skipping and Duchenne muscular dystrophy: Hope, hype and how feasible. Neurol. India 56, 254–262.CrossRefPubMedGoogle Scholar
  3. 3.
    Kang, S.H., Cho, M.J. and Kole, R. (1998) Up-regulation of luciferase gene expression with antisense oligonucleotides: implications and applications in functional assay development. Biochemistry 37, 6235–6239.CrossRefPubMedGoogle Scholar
  4. 4.
    Abes, S., Turner, J.J., Abes, R., Arzumanov, A.A., Williams, D, Owen, D, Lebleu, B. and Gait, M.J. (2009) Peptide-based delivery of steric-block PNA oligonucleotides. Methods Mol. Biol. 480, 85–99.PubMedGoogle Scholar
  5. 5.
    Richard, J.P., Melikov, K., Vives, E., Ramos, C., Verbeure, B., Gait, M.J., Chernomordik, L.V. and Lebleu, B. (2003) Cell-penetrating peptides. A re-evaluation of the mechanism of cellular uptake. J. Biol. Chem. 278, 585–590.CrossRefPubMedGoogle Scholar
  6. 6.
    Turner, J.J., Ivanova, G.D., Verbeure, B, Williams, D., Arzumanov, A.A., Abes, S., Lebleu, B. and Gait, M.J. (2005) Cell-penetrating peptide conjugates of peptide nucleic acids (PNA) as inhibitors of HIV-1 Tat-dependent trans-activation in cells. Nucleic Acids Res. 33, 6837–6849.CrossRefPubMedGoogle Scholar
  7. 7.
    Abes, S., Turner, J.J., Owen, D., Ivanova, G.D., Verbeure, B., Williams, D., Arzumanov, A.A., Clair, P., Gait, M.J. and Lebleu, B. (2007) Efficient splicing correction by PNA conjugation to an R6-Penetratin delivery peptide. Nucleic Acids Res. 35, 4495–4502.CrossRefPubMedGoogle Scholar
  8. 8.
    Ivanova, G.D., et al. (2008) Improved cell-penetrating peptide-PNA conjugates for splicing redirection in HeLa cells and exon skipping in mdx mouse muscle. Nucleic Acids Res. 36, 6418–6428.CrossRefPubMedGoogle Scholar
  9. 9.
    Abes, S., et al. (2006) Vectorization of morpholino oligomers by the (R-Ahx-R)4 peptide allows efficient splicing correction in the absence of endosomolytic agents. J. Control. Release 116, 304–313.CrossRefPubMedGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC 2011

Authors and Affiliations

  • Rachida Abes
    • 1
  • Andrey A. Arzumanov
    • 2
  • Amer F. Saleh
    • 2
  • Fatouma Said Hassane
    • 1
  • Michael J. Gait
    • 3
  • Bernard Lebleu
    • 1
  1. 1.Université MontpellierMontpellierFrance
  2. 2.Laboratory of Molecular BiologyMedical Research CouncilCambridgeUK
  3. 3.Laboratory of Molecular BiologyMedical Research CouncilCambridgeEngland

Personalised recommendations